ID   ACA2_BPZF4              Reviewed;         116 AA.
AC   H9C180;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2012, sequence version 1.
DT   18-JUN-2025, entry version 35.
DE   RecName: Full=Aca2 repressor;
DE   AltName: Full=Aca2 regulator;
DE   AltName: Full=Gene product 30;
DE            Short=Gp30;
GN   ORFNames=ZF40_0030;
OS   Pectobacterium phage ZF40 (Bacteriophage ZF40).
OC   Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes.
OX   NCBI_TaxID=1127516;
OH   NCBI_TaxID=554; Pectobacterium carotovorum (Erwinia carotovora).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=22792219; DOI=10.1371/journal.pone.0040102;
RA   Comeau A.M., Tremblay D., Moineau S., Rattei T., Kushkina A.I.,
RA   Tovkach F.I., Krisch H.M., Ackermann H.W.;
RT   "Phage morphology recapitulates phylogeny: the comparative genomics of a
RT   new group of myoviruses.";
RL   PLoS ONE 7:E40102-E40102(2012).
RN   [2]
RP   FUNCTION, SUBUNIT, DNA-BINDING, AND DOMAIN.
RX   PubMed=31428783; DOI=10.1093/nar/gkz721;
RA   Birkholz N., Fagerlund R.D., Smith L.M., Jackson S.A., Fineran P.C.;
RT   "The autoregulator Aca2 mediates anti-CRISPR repression.";
RL   Nucleic Acids Res. 47:9658-9665(2019).
RN   [3] {ECO:0007744|PDB:7VJO, ECO:0007744|PDB:7VJP}
RP   X-RAY CRYSTALLOGRAPHY (1.31 ANGSTROMS) IN COMPLEX WITH MG(2+), FUNCTION,
RP   SUBUNIT, AND MUTAGENESIS OF ARG-30; GLN-33; TYR-34 AND ARG-39.
RX   PubMed=34756887; DOI=10.1016/j.jbc.2021.101357;
RA   Liu Y., Zhang L., Guo M., Chen L., Wu B., Huang H.;
RT   "Structural basis for anti-CRISPR repression mediated by bacterial operon
RT   proteins Aca1 and Aca2.";
RL   J. Biol. Chem. 297:101357-101357(2021).
RN   [4] {ECO:0007744|PDB:7B5J}
RP   X-RAY CRYSTALLOGRAPHY (1.34 ANGSTROMS) OF 2-116, DOMAIN, AND SUBUNIT.
RX   PubMed=34116143; DOI=10.1016/j.jsb.2021.107752;
RA   Usher B., Birkholz N., Beck I.N., Fagerlund R.D., Jackson S.A.,
RA   Fineran P.C., Blower T.R.;
RT   "Crystal structure of the anti-CRISPR repressor Aca2.";
RL   J. Struct. Biol. 213:107752-107752(2021).
RN   [5] {ECO:0007744|PDB:7VJQ}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.79 ANGSTROMS) OF 1-116, FUNCTION,
RP   DOMAIN, MUTAGENESIS OF ARG-30 AND ASP-45, DNA-BINDING, AND RNA-BINDING.
RX   PubMed=38987591; DOI=10.1038/s41586-024-07644-1;
RA   Birkholz N., Kamata K., Feussner M., Wilkinson M.E., Cuba Samaniego C.,
RA   Migur A., Kimanius D., Ceelen M., Went S.C., Usher B., Blower T.R.,
RA   Brown C.M., Beisel C.L., Weinberg Z., Fagerlund R.D., Jackson S.A.,
RA   Fineran P.C.;
RT   "Phage anti-CRISPR control by an RNA- and DNA-binding helix-turn-helix
RT   protein.";
RL   Nature 631:670-677(2024).
CC   -!- FUNCTION: Represses the expression of the acrIF8-aca2 operon
CC       (PubMed:31428783, PubMed:34756887, PubMed:38987591). Regulates the
CC       transcription and translation of phage anti-CRISPR acrIF8 gene (AC
CC       H9C181), which is necessary because the expression of this gene rises
CC       rapidely upon infection to enable evasion from host CRISPR-Cas defense
CC       but is probably toxic to the host cell (PubMed:38987591). Aca2
CC       repressor can inhibit acrIF8 transcriptionally through DNA binding to 2
CC       inverted repeats in the promoter region and translationally by binding
CC       conserved RNA stem-loops on mRNAs thereby blocking ribosome access
CC       (PubMed:31428783, PubMed:38987591). Both modes of regulation together
CC       are essential for complete tight repression (PubMed:38987591).
CC       {ECO:0000269|PubMed:31428783, ECO:0000269|PubMed:34756887,
CC       ECO:0000269|PubMed:38987591}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:31428783,
CC       ECO:0000269|PubMed:34116143, ECO:0000269|PubMed:34756887}.
CC   -!- DOMAIN: The N-terminus HTH domain is involved in DNA binding and
CC       inhibition of transcription (PubMed:31428783, PubMed:34116143,
CC       PubMed:38987591). The C-terminus is involved in dimerization
CC       (PubMed:34116143). {ECO:0000269|PubMed:31428783,
CC       ECO:0000269|PubMed:34116143, ECO:0000269|PubMed:38987591}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JQ177065; AFC22482.1; -; Genomic_DNA.
DR   RefSeq; YP_007006939.1; NC_019522.1.
DR   PDB; 7B5J; X-ray; 1.34 A; A/B=2-116.
DR   PDB; 7VJO; X-ray; 1.31 A; A/B=1-116.
DR   PDB; 7VJP; X-ray; 1.59 A; A/B=1-116.
DR   PDB; 7VJQ; X-ray; 2.79 A; A/B=1-116.
DR   PDB; 8W35; EM; 2.61 A; A/B=1-116.
DR   PDBsum; 7B5J; -.
DR   PDBsum; 7VJO; -.
DR   PDBsum; 7VJP; -.
DR   PDBsum; 7VJQ; -.
DR   PDBsum; 8W35; -.
DR   EMDB; EMD-43762; -.
DR   SMR; H9C180; -.
DR   GeneID; 14012446; -.
DR   KEGG; vg:14012446; -.
DR   Proteomes; UP000005230; Segment.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.3100.10; Putative cytoplasmic protein; 1.
DR   InterPro; IPR015060; Aca2_YdiL-like.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom_sf.
DR   InterPro; IPR027910; YdiL_sf.
DR   Pfam; PF08965; Aca2_YdiL; 1.
DR   SUPFAM; SSF47413; lambda repressor-like DNA-binding domains; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Metal-binding; Reference proteome; Repressor;
KW   RNA-binding.
FT   CHAIN           1..116
FT                   /note="Aca2 repressor"
FT                   /id="PRO_0000461778"
FT   BINDING         34
FT                   /ligand="DNA"
FT                   /ligand_id="ChEBI:CHEBI:16991"
FT                   /evidence="ECO:0000269|PubMed:38987591"
FT   BINDING         92
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0007744|PDB:7VJO"
FT   MUTAGEN         30
FT                   /note="R->A: Loss of regulation by Aca2 at both the
FT                   transcription and traduction levels."
FT                   /evidence="ECO:0000269|PubMed:34756887,
FT                   ECO:0000269|PubMed:38987591"
FT   MUTAGEN         33
FT                   /note="Q->A: Loss of regulation by Aca2 at the
FT                   transcription level."
FT                   /evidence="ECO:0000269|PubMed:34756887"
FT   MUTAGEN         34
FT                   /note="Y->A: Loss of regulation by Aca2 at the
FT                   transcription level."
FT                   /evidence="ECO:0000269|PubMed:34756887"
FT   MUTAGEN         39
FT                   /note="R->A: Loss of regulation by Aca2 at the
FT                   transcription level."
FT                   /evidence="ECO:0000269|PubMed:34756887"
FT   MUTAGEN         45
FT                   /note="D->A: Specifically abrogates RNA-mediated
FT                   translational repression; no effect on transcriptional
FT                   (DNA-based) repression."
FT                   /evidence="ECO:0000269|PubMed:38987591"
FT   HELIX           3..12
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   HELIX           17..23
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   HELIX           29..37
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   STRAND          38..40
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   HELIX           44..69
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   HELIX           82..88
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   HELIX           94..109
FT                   /evidence="ECO:0007829|PDB:7VJO"
FT   STRAND          114..116
FT                   /evidence="ECO:0007829|PDB:7VJO"
SQ   SEQUENCE   116 AA;  13324 MW;  EE586E33DF557E35 CRC64;
     MTNKELQAIR KLLMLDVSEA AEHIGRVSAR SWQYWESGRS AVPDDVEQEM LDLASVRIEM
     MSAIDKRLAD GERPKLRFYN KLDEYLADNP DHNVIGWRLS QSVAALYYTE GHADLI
//
